Recent Events & Catalysts
TG Therapeutics, Inc. (TGTX) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72
Benzinga · 4d ago
TG Therapeutics: Why I'm Staying Long After The Q2 Selloff
SeekingAlpha · 8d ago
TG Therapeutics (NASDAQ:TGTX) Falls as Q2 Revenue Beats but EPS Misses, Guidance Raised Below Estimates
ChartMill · 8d ago
TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcript
SeekingAlpha · 8d ago
TG Therapeutics Raises FY2026 Sales Guidance from $925.000M to $950.000M vs $942.370M Est
Benzinga · 8d ago
TG Therapeutics Q2 EPS $0.05 Misses $0.33 Estimate, Sales $240.335M Beat $229.721M Estimate
Benzinga · 8d ago
TG Therapeutics (NASDAQ:TGTX) Meets Minervini's Trend Template with Accelerating Growth
ChartMill · 13d ago
TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update
Yahoo · 13d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-03 · 8d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-12 · 60d ago
Other events, Financial statements and exhibits
Filed 2026-06-03 · 69d ago
Other events, Financial statements and exhibits
Filed 2026-05-27 · 76d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.